GO:0008131 primary methylamine oxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008131 primary methylamine oxidase activity describes the copper-dependent oxidative deamination of primary methylamines to aldehydes, hydrogen peroxide, and ammonium.
• The reaction is catalyzed by copper-quinoprotein amine oxidases, including bacterial and yeast enzymes such as methylamine oxidase from Arthrobacter P1 and Hansenula polymorpha.
• In mammals, semicarbazide-sensitive amine oxidase (SSAO) exhibits primary amine oxidase activity and contributes to methylamine metabolism, with inhibitors like methylxanthines modulating its activity.
• Dysregulated amine oxidase activity is linked to metabolic disorders, inflammation, and host-parasite interactions, making it a target for drug discovery.
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes encoding primary methylamine oxidases and their regulators.
• Studying GO:0008131 requires integrating enzymology, structural biology, and functional genomics to dissect its roles in health and disease.
Description
Primary methylamine oxidase activity (GO:0008131) is a molecular function defined by the catalysis of the reaction: a primary methyl amine + H2O + O2 = an aldehyde + H2O2 + NH4+. This activity is characteristic of copper-containing amine oxidases (CuAOs) that utilize a quinone cofactor to oxidatively deaminate primary amines, generating reactive hydrogen peroxide and ammonium. The enzyme is widely distributed across bacteria, yeast, and mammals, where it participates in amine metabolism and detoxification. In mammals, semicarbazide-sensitive amine oxidase (SSAO) is a membrane-bound CuAO that exhibits primary amine oxidase activity toward methylamine and other endogenous amines. The reaction products, particularly H2O2 and aldehydes, can influence cellular signaling and stress responses, linking this activity to metabolic and inflammatory pathways. Understanding GO:0008131 is therefore important for researchers studying amine catabolism, oxidative stress, and related diseases. The availability of recombinant enzymes and selective inhibitors has facilitated biochemical and structural studies. Moreover, the emergence of CRISPR-based genome editing allows precise manipulation of genes encoding these enzymes, enabling functional dissection in physiologically relevant models.
primary methylamine oxidase activity At A Glance
| GO ID | GO:0008131 |
|---|---|
| GO term | primary methylamine oxidase activity |
| Ontology | molecular_function |
| Synonym | amine oxidase activity; amine oxidase (copper-containing) activity; primary amine oxidase activity; primary-amine:oxygen oxidoreductase (deaminating) activity |
| Major function | Catalysis of oxidative deamination of primary methylamines to aldehydes, H2O2, and NH4+ |
| Cofactors | Copper ion and quinone cofactor (e.g., topaquinone) |
| Subcellular location | Periplasm in bacteria; plasma membrane in mammals (SSAO) |
| Representative enzymes | Methylamine oxidase from Arthrobacter P1, Hansenula polymorpha amine oxidase, mammalian SSAO |
What Is GO:0008131?
GO:0008131 primary methylamine oxidase activity is defined as the catalysis of the reaction: a primary methyl amine + H2O + O2 = an aldehyde + H2O2 + NH4+. This activity is synonymous with amine oxidase (copper-containing) activity, primary amine oxidase activity, and primary-amine:oxygen oxidoreductase (deaminating) activity. It is a molecular function that requires copper and a quinone cofactor, and it is involved in the oxidative deamination of primary amines, producing an aldehyde, hydrogen peroxide, and ammonium.
Why Is primary methylamine oxidase activity Important in Cell Biology?
GO:0008131 primary methylamine oxidase activity is important because it governs the metabolism of primary amines, including methylamine, which can be derived from dietary sources, gut microbiota, and endogenous pathways. The reaction products, such as hydrogen peroxide and aldehydes, are bioactive and can modulate cellular signaling, oxidative stress, and inflammation. In mammals, SSAO-mediated oxidation of methylamine has been implicated in metabolic disorders, including adipose tissue dysfunction and inflammasome activation during ageing. In infectious disease, amine oxidases from parasites contribute to drug activation, as seen with aminomethyl-benzoxaboroles in trypanosomes. Thus, understanding this activity provides insights into fundamental biochemistry and potential therapeutic targets.
• Metabolic disorders: SSAO-mediated methylamine oxidation is linked to adipose tissue dysfunction and inflammasome activation in ageing.
• Inflammation: Hydrogen peroxide produced by amine oxidases can promote oxidative stress and inflammatory responses.
• Drug discovery: Inhibitors of SSAO, such as methylxanthines, modulate primary amine oxidase activity and may have therapeutic potential.
• Host-parasite interactions: Parasite amine oxidases activate prodrugs, offering targets for antiparasitic therapy.
• Biotechnology: Recombinant amine oxidases can bioconvert airborne methylamine, useful for bioremediation.
• Enzyme evolution: Bacterial and yeast methylamine oxidases provide models for studying copper-quinoprotein evolution.
• Analytical biochemistry: Selective inhibitors help distinguish SSAO from monoamine oxidases in tissue samples.
• Disease biomarkers: Altered amine oxidase activity may reflect metabolic or inflammatory states.
What Happens During primary methylamine oxidase activity?
Substrate Binding and Oxidation
In simple terms: The enzyme grabs a methylamine molecule and uses oxygen to break it down.
The catalytic cycle begins with the binding of a primary methylamine to the copper-quinoprotein active site. The quinone cofactor (e.g., topaquinone) is reduced by the amine substrate, forming a Schiff base intermediate. This step is coupled to the reduction of molecular oxygen, ultimately producing an aldehyde, hydrogen peroxide, and ammonium.
Role of Copper and Quinone Cofactor
In simple terms: Copper and a special quinone molecule work together to perform the chemistry.
Copper-containing amine oxidases possess a type 2 copper center and a quinone cofactor derived from a tyrosine residue. The copper assists in electron transfer and oxygen activation, while the quinone directly participates in substrate oxidation. This dual cofactor mechanism is essential for catalytic activity.
Product Formation and Release
In simple terms: The reaction produces an aldehyde, hydrogen peroxide, and ammonium, which are released.
Following substrate oxidation, the aldehyde product is released, and the reduced cofactor is reoxidized by molecular oxygen, generating hydrogen peroxide. Ammonium is also released as a byproduct. These products can have biological effects, such as signaling or toxicity.
Subcellular Localization and Topology
In simple terms: The enzyme is located in specific cellular compartments depending on the organism.
In bacteria such as Arthrobacter P1, methylamine oxidase is periplasmic, allowing direct access to environmental amines. In mammals, SSAO is a membrane-bound enzyme with an extracellular active site, enabling oxidation of circulating amines. This localization influences substrate availability and physiological roles.
Key Genes Involved in GO:0008131 primary methylamine oxidase activity
The following genes and proteins are directly associated with primary methylamine oxidase activity or its regulation, based on experimental evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Methylamine oxidase (Arthrobacter P1) | Bacterial copper-quinoprotein amine oxidase | Model for structure-function studies of CuAOs |
| AMO (Hansenula polymorpha) | Yeast amine oxidase for methylamine utilization | Bioconversion of airborne methylamine |
| SSAO/VAP-1 (mammalian) | Membrane-bound amine oxidase | Metabolic and inflammatory disorders |
| FMO3 | Flavin-containing monooxygenase (TMAO production) | Linked to metabolic disorders, not direct GO:0008131 but related amine metabolism |
| MAO-A | Monoamine oxidase A | Distinct from CuAOs but often studied together |
| MAO-B | Monoamine oxidase B | Inhibited by methylxanthines alongside SSAO |
| CYP2D6 | Cytochrome P450 | Not directly related, but cited for context of amine metabolism |
| Trypanosome amine oxidase | Parasite enzyme activating prodrugs | Drug target for trypanosomiasis |
| Copper chaperone (e.g., CtaA) | Copper delivery to CuAOs | Required for enzyme maturation |
| Quinone cofactor biosynthesis enzymes | Generate topaquinone | Essential for catalytic activity |
| Periplasmic amine dehydrogenase | Alternative amine oxidation pathway | Comparative studies |
| Aldehyde dehydrogenase | Detoxifies aldehyde products | Downstream metabolism |
| Catalase | Degrades hydrogen peroxide | Protects against oxidative stress |
| Ammonium transporter | Uptake of ammonium product | Nitrogen metabolism |
| Methylamine dehydrogenase | Alternative methylamine oxidation | Comparative enzymology |
| SSAO inhibitor proteins | Regulate SSAO activity | Therapeutic modulation |
How Is primary methylamine oxidase activity Regulated?
The activity of primary methylamine oxidases is regulated at multiple levels. In bacteria, expression of methylamine oxidase is induced by primary amines, ensuring efficient utilization of nitrogen sources. In mammals, SSAO activity can be modulated by endogenous inhibitors, substrate availability, and post-translational modifications. Methylxanthines, such as caffeine, inhibit SSAO and monoamine oxidase activities in human adipose tissue, suggesting dietary regulation. Additionally, copper availability and quinone cofactor biosynthesis are critical for enzyme maturation and activity. Inflammatory cytokines may influence SSAO expression, linking regulation to metabolic and immune states.
primary methylamine oxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SSAO/VAP-1 | Metabolic disorders, inflammation | Knockout mouse, adipocyte-specific overexpression |
| FMO3 | Metabolic disorders (TMAO) | Knockout and knock-in models |
| Trypanosome amine oxidase | Trypanosomiasis | Parasite knockout, drug activation assays |
| MAO-A/B | Neurological disorders | Knockout mice, inhibitor studies |
| CYP2D6 | Opioid metabolism | Pharmacogenetic models |
Metabolic Disorders and Ageing
SSAO-mediated oxidation of methylamine generates hydrogen peroxide and aldehydes, which can promote inflammasome activation and adipose tissue dysfunction during ageing. Elevated SSAO activity has been associated with metabolic disorders, making it a potential therapeutic target.
Infectious Diseases
Parasite amine oxidases, such as those in Trypanosoma, activate aminomethyl-benzoxaborole prodrugs, leading to parasite death. This highlights the potential of targeting primary methylamine oxidase activity for antiparasitic therapy.
Inflammation and Oxidative Stress
Hydrogen peroxide produced by amine oxidases contributes to oxidative stress and inflammation. Inhibitors of SSAO, such as methylxanthines, may reduce these effects, offering a strategy for managing inflammatory conditions.
From primary methylamine oxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SSAO affect methylamine metabolism? | SSAO knockout mouse or cell line |
| Can point mutations in the copper-binding site alter activity? | CRISPR point-mutation knock-in in bacterial or yeast enzyme |
| What is the effect of overexpression of amine oxidase on oxidative stress? | Overexpression cell model (e.g., HEK293) |
| How does tagged SSAO localize in cells? | Tagged knock-in (e.g., GFP) in mammalian cells |
| Can CRISPR library screening identify regulators of amine oxidase activity? | Genome-wide CRISPR knockout library in reporter cells |
| Does parasite amine oxidase knockout reduce drug activation? | CRISPR knockout in Trypanosoma |
How to Study the primary methylamine oxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Amplex Red assay | H2O2 production | Enzyme kinetics and inhibitor screening |
| HPLC | Aldehyde and amine levels | Metabolite quantification |
| X-ray crystallography | Three-dimensional structure | Active site analysis |
| CRISPR knockout | Gene function loss | Causal gene identification |
| CRISPR knock-in | Tagged or mutant protein expression | Localization and activity studies |
| RNA-seq | Transcriptional changes | Regulatory network analysis |
| Proteomics | Protein expression and modifications | Enzyme maturation and cofactor analysis |
| Metabolomics | Global metabolite profiling | Pathway flux and biomarker discovery |
Enzymatic Activity Assays
Primary methylamine oxidase activity can be measured using colorimetric or fluorometric assays that detect hydrogen peroxide or aldehyde production. For example, horseradish peroxidase-coupled assays with Amplex Red are commonly used.
Structural Biology
X-ray crystallography and cryo-EM have elucidated the structure of copper-quinoprotein amine oxidases, revealing the active site architecture and cofactor binding. These studies inform inhibitor design.
CRISPR-Based Functional Genomics
CRISPR knockout and knock-in models enable precise manipulation of genes encoding amine oxidases or their regulators. Pooled CRISPR screens can identify modifiers of methylamine sensitivity or oxidative stress.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics can quantify methylamine, aldehydes, and ammonium to assess flux through the oxidase pathway in cells and tissues.
How CRISPR Can Be Used to Study GO:0008131 primary methylamine oxidase activity
Knockout
CRISPR knockout of genes encoding primary methylamine oxidases (e.g., SSAO) or their cofactor biosynthesis enzymes can abolish activity, enabling studies of downstream metabolic and signaling effects. Knockout models are essential for validating drug targets.
Point Mutation
Introducing point mutations in the copper-binding or quinone-forming residues via CRISPR can dissect catalytic mechanisms and cofactor requirements. Such models help distinguish between copper-dependent and independent functions.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of amine oxidases allows real-time imaging and affinity purification. Knock-in of disease-associated variants can model human mutations.
Overexpression
CRISPR activation or cDNA overexpression of amine oxidases can elevate activity, useful for studying oxidative stress and metabolic consequences. Overexpression models complement knockout studies.
How EDITGENE Supports primary methylamine oxidase activity Research
Researchers studying primary methylamine oxidase activity-related genes often need to determine whether a candidate gene is causally involved in amine metabolism, oxidative stress, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, accelerating functional validation and therapeutic development.
Contact EDITGENE today to design your custom CRISPR model for primary methylamine oxidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| VCAM1 Knockout HEK293 Cell Line | EDJ-KQ146 | Human | 7412 | Details Get a Quote |
| MAOA Knockout HEK293T Cell Line | EDJ-KQ219 | Human | 4128 | Details Get a Quote |
| MAOA Knockout HEK293 Cell Line | EDJ-KQ2873 | Human | 4128 | Details Get a Quote |
| MAOB Knockout HEK293 Cell Line | EDJ-KQ2895 | Human | 4129 | Details Get a Quote |
| AOC1 Knockout HEK293 Cell Line | EDJ-KQ3988 | Human | 26 | Details Get a Quote |
| AOC2 Knockout HEK293 Cell Line | EDJ-KQ4060 | Human | 314 | Details Get a Quote |
| AOC3 Knockout HEK293 Cell Line | EDJ-KQ6315 | Human | 8639 | Details Get a Quote |
| MAOB Knockout HCT 116 Cell Line | EDJ-KQ23970 | Human | 4129 | Details Get a Quote |
| AOC2 Knockout A-549 Cell Line | EDJ-KQ25085 | Human | 314 | Details Get a Quote |
| AOC3 Knockout A-549 Cell Line | EDJ-KQ28922 | Human | 8639 | Details Get a Quote |
| MAOB Knockout HeLa Cell Line | EDJ-KQ22600 | Human | 4129 | Details Get a Quote |
| MAOA Knockout A-549 Cell Line | EDJ-KQ25292 | Human | 4128 | Details Get a Quote |
| MAOA Knockout HCT 116 Cell Line | EDJ-KQ25294 | Human | 4128 | Details Get a Quote |
| MAOA Knockout HeLa Cell Line | EDJ-KQ25295 | Human | 4128 | Details Get a Quote |
| AOC1 Knockout HeLa Cell Line | EDJ-KQ26302 | Human | 26 | Details Get a Quote |
Displaying Records 1 To 15 Of 26 Records
Frequently Asked Questions About primary methylamine oxidase activity
What is primary methylamine oxidase activity?
It is a molecular function (GO:0008131) that catalyzes the oxidative deamination of primary methylamines to aldehydes, hydrogen peroxide, and ammonium, using copper and a quinone cofactor.
What genes are involved in primary methylamine oxidase activity?
Genes encoding copper-quinoprotein amine oxidases, such as methylamine oxidase from Arthrobacter P1, AMO from Hansenula polymorpha, and mammalian SSAO/VAP-1, are directly involved.
What is the reaction catalyzed by primary methylamine oxidase?
The reaction is: a primary methyl amine + H2O + O2 = an aldehyde + H2O2 + NH4+.
How is primary methylamine oxidase activity regulated?
It is regulated by substrate availability, copper and quinone cofactor biosynthesis, and inhibitors such as methylxanthines.
What diseases are associated with primary methylamine oxidase activity?
It has been linked to metabolic disorders, inflammation, and infectious diseases such as trypanosomiasis.
What are the inhibitors of primary methylamine oxidase?
Selective inhibitors include semicarbazide and methylxanthines like caffeine, which inhibit SSAO and monoamine oxidases.
How can I study primary methylamine oxidase activity in the lab?
Common methods include enzymatic assays (Amplex Red), CRISPR knockout/knock-in models, and metabolomics.
What is the difference between SSAO and MAO?
SSAO is a copper-containing amine oxidase sensitive to semicarbazide, while MAOs are flavin-dependent enzymes; both oxidize amines but have distinct substrate specificities and inhibitor profiles.
Can CRISPR be used to study primary methylamine oxidase activity?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise manipulation of genes encoding these enzymes and their regulators.
What model organisms are used to study primary methylamine oxidase activity?
Bacteria (Arthrobacter P1), yeast (Hansenula polymorpha), and mammals (including humans) are common models.
Conclusion
GO:0008131 primary methylamine oxidase activity represents a fundamental biochemical function with broad implications for metabolism, inflammation, and infectious disease. The copper-quinoprotein enzymes that catalyze this reaction are conserved across species and serve as valuable models for enzymology and drug discovery. Advances in CRISPR genome editing now allow researchers to precisely manipulate these genes, accelerating the translation of basic findings into therapeutic strategies. Continued investigation of primary methylamine oxidase activity will likely uncover new roles in health and disease.
References
- 1. Ganapathy T et al.. 2025. Adipocyte FMO3-derived TMAO induces WAT dysfunction and metabolic disorders by promoting inflammasome activation in ageing.. Nat Commun 16(1):8873 PMID: 41053195
- 3. Haj Ahmed W et al.. 2020. Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue.. Medicines (Basel) 7(4) PMID: 32252407
- 4. Sherlock LA et al.. 1986. A new type of methylamine oxidase: the sole oxidase produced during growth of Sporobolomyces albo-rubescens on primary alkylamines.. Yeast 2(2):87-92 PMID: 3505743
- 5. Sigawi S et al.. 2014. Bioconversion of airborne methylamine by immobilized recombinant amine oxidase from the thermotolerant yeast Hansenula polymorpha.. ScientificWorldJournal 2014:898323 PMID: 24672387
- 6. Kinemuchi H et al.. 2004. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.. Neurotoxicology 25(1-2):325-35 PMID: 14697907
- 7. van Iersel J et al.. 1986. Methylamine oxidase from Arthrobacter P1. A bacterial copper-quinoprotein amine oxidase.. Eur J Biochem 161(2):415-9 PMID: 3780750
- 8. Zhang N et al.. 2018. Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles.. PLoS Pathog 14(2):e1006850 PMID: 29425238
